Joel Bierer

Cardiac Surgery Resident Physician, Medical Research Ph.D. Candidate, Dalhousie University

[Takhliq Amir, MD @takhliqamir]

Congrats to my superstar co-resident @jbierer for winning both the Dr. Paul Cartier Award & the Richard Rowe Competition for his incredible research @SCC_CCS #CCC23! Can't believe he has time for this in between all the life advice I can always depend on him for 😉🥳
@cscs_sccc

[Saurabh Gupta, MD MSc FRCSC @soreabg]

A HUGE congratulations to this year's Dr Paul Cartier Cardiac Surgery Awardee, @jbierer!!!
Humbled to be on the same list as you, Joel. In awe of you and your work.

@cscs_sccc @SCC_CCS @ansarhassan99 @OuzounianMD @jean_legare @TheRakeshArora

[Joel Bierer @jbierer]

“If we have seen further it is by standing on the shoulders of Giants.” You had to be there. #AATS2023 #CHSS

[JAMA @JAMA_current]

In this randomized clinical trial, among infants undergoing heart surgery, delivery of nitric oxide into the cardiopulmonary bypass did not increase ventilator-free survival at 28 days. https://t.co/VJzBLPOP6U

[Peter Munk Cardiac Centre @PMunkCardiacCtr]

This weekend we celebrated the career of Dr. Chris Feindel and the legacy he leaves behind as he transitions into retirement. Special thanks to @drbarryrubin @OuzounianMD Dr. Rao & Dr. David for sharing their fondest memories & experiences working alongside one of the very best.

[Richard G. Ohye, M.D @RickOhyeMD]

Congrats to the @MottChildren cath lab for enrolling their first patient in the COMPASS trial comparing stent vs. shunt for pulmonary blood flow. https://t.co/7NartbQM3M S.O. to Study Co-Chairs and @MottDocs @JennaRomanoMD, @jeffzampi & @skpasquali for their leadership.

[Joel Bierer @jbierer]

Excellent second day at the World Society for Pediatric and Congenital Heart Surgery annual meeting focusing on Tetralogy of Fallot in the beautiful city of Marrakech, Morocco. #wspchs

[Joel Bierer @jbierer]

Achieving the foundational goals of coronary bypass surgery, using innovative revascularization techniques in select patients and strictly adhering to long-term medical therapy optimizes outcomes for patients with coronary artery disease. #sts #coronaryconference

[NEJM @NEJM]

In this trial, patients with three-vessel coronary artery disease, PCI guided by assessment of fractional flow reserve was not noninferior to CABG with respect to the composite end point of death, myocardial infarction, stroke, or repeat revascularization. https://t.co/uYZGZWub0T

[NEJM @NEJM]

In a randomized trial involving patients undergoing mitral-valve surgery for degenerative mitral regurgitation, the addition of tricuspid repair resulted in a lower risk of worsening regurgitation or death. #AHA21 https://t.co/zBNNzSiby8

[Joel Bierer @jbierer]

The future of CABG is bright. #EACTS2021 @EACTS

[NEJM @NEJM]

In a randomized trial, 4,811 patients with atrial fibrillation were assigned to undergo or not undergo left atrial appendage occlusion during cardiac surgery. At 3.8 years, the risk of ischemic stroke or systemic embolism was significantly lower with occlusion. #ACC21

[Autocar @autocar]

Mercedes-AMG One update: Delayed hypercar hits the track in advanced testing phase https://t.co/GXbOKW8sk4

[NEJM @NEJM]

Intermediate-risk patients with aortic stenosis were randomized to transcatheter or surgical aortic-valve replacement (AVR). At five years, there was no significant difference between groups in the rate of death or disabling stroke. https://t.co/mNRr419aZa

[NEJM @NEJM]

In a randomized, placebo-controlled trial involving 4745 patients with recent myocardial infarction, low-dose colchicine (0.5 mg once daily) prevented ischemic cardiovascular events. https://t.co/H2eubZ6HRD

[NEJM @NEJM]

#VisualAbstract: A randomized, multicenter trial that compared endovascular repair with open repair of abdominal aortic aneurysm showed no significant difference between these approaches in overall survival after 8 years. Read the full text abstract: https://t.co/AcXsGTe5xW

[NEJM @NEJM]

In the Evolut Low Risk trial, 1468 patients with severe aortic stenosis who were at low risk for death with surgery were assigned to either TAVR with a self-expanding valve or surgical aortic-valve replacement. Read the full abstract: https://t.co/F1Bp7a2qR5

[NEJM @NEJM]

In the PARTNER 3 trial, 1000 patients w/ severe aortic stenosis who were at low risk for death with surgery were assigned to undergo transcatheter aortic-valve replacement with a balloon-expandable valve or surgical aortic-valve replacement. Full results: https://t.co/LNVJq3GqWS

[NEJM @NEJM]

#VisualAbstract (with corrected image): Centrifugal-Flow or Axial-Flow Left Ventricular Assist Device (MOMENTUM 3) https://t.co/xdwZLYvcCG #HeartFailure

[NEJM @NEJM]

Original Article: Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years https://t.co/6Zx8Y9Et0O #CABG